Towards a Comprehensive Understanding of Bipolar Disorder: In Vivo MRS Investigation of the Phosphatidylinositol Cycle

At present, both the neuropathophysiology of bipolar disorder as well as the mechanism(s) through which current mood-stabilizing agents provide symptom relief are unknown. Through the recent utilization of magnetic resonance spectroscopy (MRS), progress has been made; with optimistic interest being focused on the phosphatidylinositol (PI) cycle as a likely neuropathophysiological factor in bipolar disorder. The present manuscript reviews this interesting and promising area, placing emphasis on the magnetic resonance spectroscopy investigations of PI- cycle function in bipolar disorder reported to date. While relatively few well-designed MRS studies have investigated PI-cycle function in bipolar disorder, current evidence does lend support to PI-cycle involvement in bipolar neuropathophysiology as a means through which mood-stabilizing agents act; pointing to PI-cycle dysfunction as an important neuropathophysiological factor in bipolar disorder. However, there still remains a dearth of information about this interesting hypothesis. In addition to lithium, more data is needed regarding the effects on PI-cycle function of the other commonly prescribed mood-stabilizing agents. As well, studies investigating the temporal relationship between medication effect on PI-cycle functioning and symptom improvement are warranted. In tandem with clinical MRS investigation of bipolar disorder, further preclinical study of the neurochemical effects of mood-stabilizing agents is needed. Finally, greater methodological rigor needs to be implemented during the design phase of any future MRS investigation into bipolar disorder, with particular attention aimed at recruiting a large homogenous sample of bipolar patients.

• Publication year

  2020

• Venue

  McGill Journal of Medicine

• Publication date

  2020-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.26443/MJM.V8I1.517
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders.

  2025cited by this paper
• Stahl's Self-Assessment Examination in Psychiatry: Psychosis and Antipsychotics

  2012cited by this paper
• Reduced intracellular pH in the basal ganglia and whole brain measured by 31P‐MRS in bipolar disorder

  2004cited by this paper
• Spotlight on Lamotrigine in Bipolar Disorder

  2004cited by this paper
• Chronic Lithium Treatment Attenuates Intracellular Calcium Mobilization

  2004cited by this paper
• Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents.

  2003cited by this paper
• Decreased N-acetylaspartate in children with familial bipolar disorder.

  2003cited by this paper
• A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

  2003cited by this paper
• Quantification of Metabolic Differences in the Frontal Brain of Depressive Patients and Controls Obtained by 1H-MRS at 3 Tesla

  2003cited by this paper
• MR Spectroscopy of the Brain

  2003cited by this paper
• Neurotransmitter interactions in psychotropic drug action: beyond dopamine and serotonin.

  2003cited by this paper
• What Drugs Are Best for Bipolar Depression?

  2003cited by this paper
• A common mechanism of action for three mood-stabilizing drugs

  2002cited by this paper
• Bipolar Disorders: 100 Years After Manic-Depressive Insanity

  2002cited by this paper
• Classification, Diagnosis and Boundaries of Bipolar Disorders

  2002cited by this paper
• Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy.

  2002cited by this paper
• Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients

  2002cited by this paper
• What makes a drug a primary mood stabilizer?

  2002cited by this paper
• Decreased Anterior Cingulate Myo-inositol/Creatine Spectroscopy Resonance with Lithium Treatment in Children with Bipolar Disorder

  2001cited by this paper
• Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder.

  2001cited by this paper
• Global „Burden of Disease”-Study for Psychiatric Disorders

  2001cited by this paper
• Effect of lithium on phosphoinositide metabolism in human brain: a proton decoupled (31)P magnetic resonance spectroscopy study.

  2001cited by this paper
• Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain.

  2000cited by this paper
• Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.

  2000cited by this paper
• Altered brain energy metabolism in lithium-resistant bipolar disorder detected by photic stimulated 31P-MR spectroscopy

  2000cited by this paper
• Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder

  1999cited by this paper
• The evolving bipolar spectrum. Prototypes I, II, III, and IV.

  1999cited by this paper
• Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness.

  1999cited by this paper
• Effects of lithium and amphetamine on inositol metabolism in the human brain as measured by 1H and 31P MRS.

  1999cited by this paper
• Lithium therapy at the millennium: a revolutionary drug used for 50 years faces competing options and possible demise.

  1999cited by this paper
• Mood stabilizers in the prevention of recurrent affective disorders: a meta‐analysis

  1999cited by this paper
• A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

  1999cited by this paper
• Neuroimaging and the Psychiatry of Late Life

  1998cited by this paper
• Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder.

  1998cited by this paper
• Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla.

  1998cited by this paper
• 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients

  1998cited by this paper
• The emerging epidemiology of hypomania and bipolar II disorder.

  1998cited by this paper
• Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity

  1998cited by this paper
• Disruption by Lithium of Phosphoinositide Signalling in Cerebellar Granule Cells in Primary Culture

  1998cited by this paper
• Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study.

  1997cited by this paper
• Treatment of mania, mixed state, and rapid cycling.

  1997cited by this paper
• Clinical MR Spectroscopy: First Principles

  1997cited by this paper
• Chronic lithium does not alter human myo-inositol or phosphomonoester concentrations as measured by 1H and 32P MRS

  1997cited by this paper
• Chronic lithium does not alter human myo-inositol or phosphomonoester concentrations as measured by 1H and 31P MRS.

  1996cited by this paper
• Mania, psychosis, and antipsychotics.

  1996cited by this paper
• Treatment-resistant bipolar depression.

  1996cited by this paper
• The Global Burden of Disease

  1996cited by this paper
• Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS

  1995influential reference
• Abnormal frontal lobe phosphorous metabolism in bipolar disorder.

  1995cited by this paper
• Decreased temporal lobe phosphomonoesters in bipolar disorder.

  1995cited by this paper
• Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder.

  1994cited by this paper
• Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy.

  1994cited by this paper
• Magnetic resonance imaging.

  1994cited by this paper
• Lithium and myo-inositol homeostasis.

  1993cited by this paper
• Comparative Effects of Lithium on the Phosphoinositide Cycle in Rat Cerebral Cortex, Hippocampus, and Striatum

  1993cited by this paper
• Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy.

  1993cited by this paper
• Lithium Effects on Inositol Phospholipids and Inositol Phosphates: Evaluation of an In Vivo Model for Assessing Polyphosphoinositide Turnover in Brain

  1992cited by this paper
• Inositol Lipids and Signal Transduction in the Nervous System: An Update

  1992cited by this paper
• Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy.

  1992cited by this paper
• Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients

  1992cited by this paper
• Measurement of brain phosphoinositide metabolism in bipolar patients using in vivo 31P-MRS.

  1991cited by this paper
• Manic-Depressive Illness

  1990cited by this paper
• Neural and developmental actions of lithium: a unifying hypothesis.

  1989cited by this paper
• One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites.

  1988cited by this paper
• Dextroamphetamine-induced arousal in human subjects as a model for mania

  1986cited by this paper
• Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands.

  1982cited by this paper
• Increased brain myo-inositol 1-phosphate in lithium-treated rats.

  1976cited by this paper
• Reduced brain inositol in lithium-treated rats.

  1971cited by this paper
• MANIC DEPRESSIVE ILLNESS

  1970cited by this paper
• One Hundred Years of Psychiatry.

  1964cited by this paper
• Lithium salts in the treatment of psychotic excitement.

  1949cited by this paper

• No citing papers are available for this paper.